# Nanobiotix S.A. (NBTX)

> Healthcare · FR · Reports in EUR

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/NBTX/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | € 30.13M | € -24.35M | € -34.52M | € 95.32M | € -84.48M |
| 2024 | € -7.45M | € -70.59M | € -21.13M | € 50.90M | € -65.70M |
| 2023 | € 38.42M | € -42.13M | € -13.59M | € 50.57M | € -1.84M |
| 2022 | € 5.22M | € -62.29M | € -40.62M | € 53.17M | € -27.05M |
| 2021 | € 3.16M | € -56.05M | € -35.89M | € 46.02M | € 26.79M |
| 2020 | € 2.91M | € -42.05M | € -34.59M | € 48.98M | € 70.47M |
| 2019 | € 3.17M | € -63.55M | € -52.75M | € 44.53M | € -1.91M |
| 2018 | € 4.40M | € -38.38M | € -33.39M | € 20.52M | € 14.24M |
| 2017 | € 4.78M | € -33.57M | € -28.62M | € 4.73M | € 43.92M |
| 2016 | € 7.06M | € -28.48M | € -24.32M | € 5.67M | € 17.40M |
| 2015 | € 5.28M | € -22.37M | € -24.10M | € 4.60M | € 15.61M |
| 2014 | € 3.65M | € -12.60M | € -12.57M | € 2.32M | € 30.32M |
| 2013 | € 2.10M | € -10.72M | € -9.25M | € 1.11M | € 3.18M |
| 2012 | € 98.5K | € -7.08M | € -5.09M | € 1.43M | € 10.70M |
| 2011 | € 1.85M | € -7.12M | € -6.61M | € 822.2K | € 925.5K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -1.13 |
| Liabilities / Eq | -1.80 |
| Current Ratio | 1.09 |

## Other views

- [Metrics](https://sponda.capital/en/NBTX.md)
- [Charts](https://sponda.capital/en/NBTX/charts.md)
- [Compare](https://sponda.capital/en/NBTX/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.